BioAnalysis LLC, founded in 2019 by Lake N. Paul in Philadelphia’s Kensington neighborhood, is a Collaborative Research Organization providing analytical services for the biopharma industry. A certified Minority Business Enterprise with more than 30 associates, the company specializes in analytical method development, GMP qualification and validation, CMC strategy, and quality control for gene therapy, biotherapeutics, and life science programs across the product lifecycle.
BioAnalysis developed BASIS, a proprietary AUC software and the only GMP-compliant option meeting FDA requirements for gene and cell therapy approvals, helping bring treatments for rare diseases to market. Rooted in Kensington, the company invests locally through jobs, a year-round paid internship program for underserved and minority individuals, and sustained support of organizations including Hope Works, Kensington Corridor Trust, Kensington Voice, and the Community Center at Visitation.
Company Information
- City
- Philadelphia
- State
- Pennsylvania
- Website
- https://www.bioanalysisllc.com
- Growth Rate
- 654.40%
- 2024 Revenue
- $5MM - $10MM
- Leadership
- BIPOC-Owned/Led, Woman-Owned/Led